Will Pharma’s Future Be Based On The Carl Icahn Business Model?
3.4.2014 | Forbes
By Steve Brozak
For today, the buzz surrounding Carl Icahn derives from his initiative to separate PayPal from eBay. More frequently, people tend to equate Icahn with his investment strategy; including his activism in Apple and significant profits in Netflix ownership. But an Icahn initiative that is drawing less attention and may have far greater social impact is his activism in the upcoming merger of Actavis and Forest Laboratories.
For the full article, please click here.